Navigation Links
Unigene Reports Third Quarter 2011 Financial Results
Date:11/9/2011

ence call and live audio webcast today, November 9, 2011 at 11 a.m., ET to discuss the third quarter 2011 results.

Interested participants and investors may access the conference call at 11 a.m., ET by dialing 800-259-0251 (U.S./Canada) or 617-614-3671 (international); participant code 29191227.  An audio webcast, along with a presentation, can be accessed by logging on to the Investors & Media section under the Events tab of the Unigene web site, www.unigene.com.

A telephonic replay of the call will be available for seven days beginning at 2 p.m., ET on November 9. Access numbers for this replay are 888-286-8010 (U.S./Canada) and 617-801-6888 (international); participant code 44127298.  The webcast replay will remain available in the Investors section of the Unigene Laboratories web site for 30 days.

About Unigene Laboratories, Inc.Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements, including with respect to clinical studies of our licensees. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees of future performance a
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
2. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
3. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
4. GenVec Reports Third Quarter 2011 Financial Results
5. Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011
6. Allied Healthcare Products Reports First Quarter Loss on Sales Decline
7. ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis
8. Stereotaxis Reports Third Quarter Financial Results
9. Isis Reports Financial Results and Highlights for Third Quarter 2011
10. Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
11. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 The board of ... LLY ) has declared a dividend for the third ... common stock. The dividend is payable ... close of business on August 15, 2013. ... portfolio of pharmaceutical products by applying the latest research ...
(Date:6/18/2013)... , June 18, 2013 Remedy Informatics, ... healthcare and life sciences research, today announced it ... (GSA) IT Schedule 70 supply contract (GS-35F-367AA, effective ... provide innovative IT solutions to government agencies at ... this contract, Remedy has placed its products and ...
(Date:6/18/2013)...   Polymer Technology Systems, Inc. (PTS) ... to integrate the CardioChek ® PA ... health systems across the country. The CardioChek PA ... through Hanson Medical Systems , offers immediate, ... cholesterol, triglycerides, and glucose. (Logo: ...
Breaking Medicine Technology:Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3
... Inc. (OTC,Bulletin Board: GOVX), http://www.geovax.com, an Atlanta ... the select few to move,forward into Phase 2a human ... supported by the National Institutes of Health (NIH)., ... fifth [5th] HIV/AIDS,vaccine to be selected to move forward ...
... LOS ALTOS, Calif., Feb. 25 InteKrin ... focused on the,development and commercialization of novel ... metabolic disease, announced today that it has,initiated ... with its lead product,candidate INT131, a non-TZD ...
Cached Medicine Technology:GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials 2GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials 3GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials 4InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
(Date:6/18/2013)... New York (PRWEB) June 18, 2013 ... dedicated to protecting the rights of victims injured by ... University’s independent review of Medtronic’s Infuse bone graft products ... Internal Medicine, a medical journal, the two studies serve ... difference in effectiveness” when comparing Infuse and the traditional ...
(Date:6/18/2013)... Biomet hip lawsuit claims ... in a multidistrict litigation in U.S. District Court, Northern ... to court records, the litigation’s most recent status conference ... Court also convened a motions hearing and a tutorial ... Biomet hip replacement litigation. The proceeding’s next Status ...
(Date:6/18/2013)... shown that cancer cells have a much different ... scientists at The University of Texas at Dallas have ... strategy to combat lung cancer. , In an article ... ONE , UT Dallas researchers compared the metabolic characteristics ... taken from the same patient. , They found ...
(Date:6/18/2013)... More than 1.1 million people in the ... to the Centers for Disease Control and Prevention (CDC). Of ... support of National HIV Testing Day on June 27, Allsup, ... (SSDI) representation, the CDC and other organizations are raising awareness ... reports about 50,000 new HIV infections each year. Along with ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3
... , ... used to capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS ... electronic stethoscope is a favorite in broadcasting - this may be the biggest audience to ... ...
... without harm to neck, researchers find , SUNDAY, Feb. 7 ... head injury by 35 percent and don,t increase the risk ... believe that helmets may increase the risk of neck injury ... greater head-to-body ratio. , In this study, Canadian researchers analyzed ...
... ... their new ReActive™ Court Surface. , ... Salt Lake City, Utah (PRWEB) February 7, 2010 -- SnapSports today announced the release ... system is its adherence to metric standards, while still utilizing all of the patented performance ...
... greater social support, researchers say , FRIDAY, Feb. 5 (HealthDay ... social standing, a new study suggests. , Researchers conducted PET ... levels of social status and social support. The results suggest ... density of dopamine D2/D3 receptors in an area of the ...
... ... Providence Hospital in Washington, D.C., where she began her nursing career more than 30 years ago. ... ... named President and CEO of Providence Hospital in Washington, D.C., where she began her nursing career ...
... MedicalSpaMD ... a MedicalSpaMD Select Partner, Shine Teeth Whitening gives every aesthetic practice a way to ... training and no equipment required. , ... Salt Lake City, UT (Vocus) February 6, 2010 -- MedicalSpaMD is ...
Cached Medicine News:Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2Health News:SnapSports Releases ReActive Court Surfacing For The International Sports Market 2Health News:Dopamine Levels in Brain May Determine Social Status 2Health News:Providence Hospital Selects Amy Freeman as President and CEO 2Health News:Providence Hospital Selects Amy Freeman as President and CEO 3Health News:MedicalSpaMD Announces Exciting New Partnership 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: